Jiang, Y.; Long, Y.; Ji, H.; Qiao, P.; Liu, Q.; Xia, X.; Qin, C.; Zhang, Y.; Lan, X.; Gai, Y.
Development and Evaluation of a Peptide Heterodimeric Tracer Targeting CXCR4 and Integrin αvβ3 for Pancreatic Cancer Imaging. Pharmaceutics 2022, 14, 1791.
https://doi.org/10.3390/pharmaceutics14091791
AMA Style
Jiang Y, Long Y, Ji H, Qiao P, Liu Q, Xia X, Qin C, Zhang Y, Lan X, Gai Y.
Development and Evaluation of a Peptide Heterodimeric Tracer Targeting CXCR4 and Integrin αvβ3 for Pancreatic Cancer Imaging. Pharmaceutics. 2022; 14(9):1791.
https://doi.org/10.3390/pharmaceutics14091791
Chicago/Turabian Style
Jiang, Yaqun, Yu Long, Hao Ji, Pengxin Qiao, Qingyao Liu, Xiaotian Xia, Chunxia Qin, Yongxue Zhang, Xiaoli Lan, and Yongkang Gai.
2022. "Development and Evaluation of a Peptide Heterodimeric Tracer Targeting CXCR4 and Integrin αvβ3 for Pancreatic Cancer Imaging" Pharmaceutics 14, no. 9: 1791.
https://doi.org/10.3390/pharmaceutics14091791
APA Style
Jiang, Y., Long, Y., Ji, H., Qiao, P., Liu, Q., Xia, X., Qin, C., Zhang, Y., Lan, X., & Gai, Y.
(2022). Development and Evaluation of a Peptide Heterodimeric Tracer Targeting CXCR4 and Integrin αvβ3 for Pancreatic Cancer Imaging. Pharmaceutics, 14(9), 1791.
https://doi.org/10.3390/pharmaceutics14091791